Reviewed by Michael Gill, B. Sc.
25 Canada Prostate Cancer Clinical Trials Near Me
Top Hospitals for Canada Prostate Cancer Clinical Trials
Image of Princess Margaret Cancer Centre in Ontario.
Princess Margaret Cancer Centre
7Active Trials
0All Time Trials for Canada Prostate Cancer
2013First Canada Prostate Cancer Trial
Image of Memorial Sloan Kettering Cancer Center in New York.
Memorial Sloan Kettering Cancer Center
New York
7Active Trials
0All Time Trials for Canada Prostate Cancer
2019First Canada Prostate Cancer Trial
Top Cities for Canada Prostate Cancer Clinical Trials
Image of Toronto in Ontario.
55Active Trials
Princess Margaret Cancer CentreTop Active Site
Canada Prostate Cancer Clinical Trials by Phase of Trial
Phase 1 Canada Prostate Cancer Clinical Trials
4Active Canada Prostate Cancer Clinical Trials
4Number of Unique Treatments
34Number of Active Locations
ARV-110 in Combination with AbirateroneacapatamabEPI-7386 (QD)Hyperpolarized Pyruvate (13C)
Canada Prostate Cancer Clinical Trials by Age Group
18+ Canada Prostate Cancer Clinical Trials
91Active Canada Prostate Cancer Clinical Trials
docetaxelARV-110 in Combination with Abirateronetalazoparib plus enzalutamidePSMA PET/CT guided intensification of therapyRadiation TherapyAbiraterone acetate (AA)CapivasertibAB680
Top Treatments for Canada Prostate Cancer Clinical Trials
Treatment Name
Active Canada Prostate Cancer Clinical Trials
All Time Trials for Canada Prostate Cancer
First Recorded Canada Prostate Cancer Trial
Radiation Therapy
Stereotactic Body Radiation Therapy (SBRT)

What Are Prostate Cancer Canada Clinical Trials?

Prostate cancer starts in the prostate gland cells, which are only found in males, where the cancerous malignant tumor consists of cancer cells that can grow into nearby tissue and destroy it. The tumor can also metastasize into other body parts. The gland is responsible for making some of the fluid that is a part of semen.

There are multiple types of prostate cancer, but adenocarcinomas are the most common. It accounts for 95% of all prostate cancers. Prostate cancer grows slowly and can be removed entirely or managed if diagnosed early. Many prostate cancer clinical trials focus on identifying new drugs for treatment.

Why Is Prostate Cancer Canada Being Studied Through Clinical Trials?

Prostate cancer is the 4th most common cancer in Canada, with 1 in 9 Canadian men expected to be diagnosed in their lifetime. Prostate cancer is often caused due to family history, aging, racial or cultural background, or inherited gene mutations. The older the man gets, the higher the chances of getting prostate cancer.

Prostate cancer can spread to other body parts, such as your bladder, or travel through your bloodstream or lymphatic system to your bones or other organs. If not diagnosed early, management becomes challenging.

What Are The Types of Treatments Available For Prostate Cancer in Canada?

There are multiple treatment options available for prostate cancer. For each patient, a specific healthcare plan will be developed based on their type and stage of cancer, grade, personal preference, and risk levels. Patients can opt for surgery, prostatectomy, or radiation therapy.

Doctors who think your prostate cancer won’t proliferate recommend expectant management. This can be performed through active surveillance by closely monitoring the prostate cancer by performing prostate specific antigen (PSA) tests and prostate biopsies regularly. Cancer will only be treated if it causes symptoms or grows.

What Are Some Recent Breakthrough Clinical Trials For Prostate Cancer Canada?

2017: Diagnosis and Treatment - this study concludes that the emergence of biomarkers, functional imaging, and magnetic resonance are optimal for prostate cancer diagnosis. Moreover, initial treatment with chemotherapy can improve survival compared with androgen deprivation therapy. Abiraterone, enzalutamide, and other agents can improve outcomes in men with metastatic prostate cancer resistant to traditional hormonal therapy.

2018: Recent Advances In Treatment And Drug Discovery - this study concludes that identifying molecular biomarkers greatly aids in selecting the drug sequence and combination for prostate cancer treatment. In addition, a classification system based on genome-wide transcriptome profiles has emerged in recent years. It will help support treatment choices for early- and late-stage diseases.

Who Are Some Of The Key Opinion Leaders / Researchers / Institutions Conducting Prostate Cancer Canada Clinical Trial Research?

Prostate Cancer Clinical Trials Consortium (PCCTC)

The Prostate Cancer Clinical Trials Consortium (PCCTC) is a clinical research group sponsored by the (PCRP). They design, implement, and complete process-driven clinical trials, translating scientific discoveries to improved standards of care.

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 7th, 2021

Last Reviewed: November 6th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.